Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. Investors

GeneDX Holdings (NASDAQ: WGS) faces a class action lawsuit alleging executives made false statements about the company's financial performance. On May 4, 2026, GeneDX disclosed missed Q1 results, cut 2026 guidance by over $60 million, reported lower-than-expected reimbursement rates, and took a $31.3 million goodwill impairment charge on its Fabric Genomics acquisition. The stock fell 49% following the announcement.